GPR35 agonist 3
GPR35 agonist 3 is a synthetic GPR35 agonist with an EC50value of 1.4 μM. GPR35 agonist 3 can be used for the research of various diseases, such as gastric cancer, type 2 diabetes, cardiovascular diseases, immune system and peripheral nervous system[1].
Product Specifications
CAS Number
[123021-85-2]
UNSPSC
12352005
Hazard Statement
H319
Target
GPR35
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease; Inflammation/Immunology; Neurological Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/gpr35-agonist-3.html
Purity
98.32
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(O)COC1=CC=C(/C=C(SC(N2)=O)\C2=O)C=C1
Molecular Formula
C12H9NO5S
Molecular Weight
279.27
Precautions
H319
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
PDGFRA (Y754) (Alpha-type Platelet-derived Growth Factor Receptor, PDGF-R-alpha, CD140 Antigen-like Family Member A, CD140a Antigen, CD140a) (MaxLight 650)
PDGFRA (Y754) (Alpha-type Platelet-derived Growth Factor Receptor, PDGF-R-alpha, CD140 Antigen-like Family Member A, CD140a Antigen, CD140a) (MaxLight 650)
Recombinant Stenotrophomonas maltophilia UPF0745 protein Smlt4554 (Smlt4554)
Recombinant Stenotrophomonas maltophilia UPF0745 protein Smlt4554 (Smlt4554)